Members of TMEMs have been observed abnormal expression in many cancers, such as the downregulation of TMEM106A resulted from the hypermethylation of promoter region in GC cell lines34 and abnormal expression of TMEM176A and 176B in breast, lymph, skin, and liver cancer.16 This evidence concerns the gene TMEM176A and cancer.